Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» muscular dystrophy
muscular dystrophy
Sarepta adds another gene therapy to its ever-expanding pipeline
Biopharma Dive
Wed, 08/4/21 - 10:40 pm
Sarepta Therapeutics
muscular dystrophy
Limb Girdle Muscular Dystrophy
Sarepta, in shadow of FDA setback, marks gene therapy progress
BioPharma Dive
Fri, 10/4/19 - 12:36 pm
Sarepta Therapeutics
SRP-9003
limb-girdle muscular dystrophy
muscular dystrophy
gene therapy
Suvodirsen For Duchenne Muscular Dystrophy Selected for FDA Complex Innovative Trial Designs Pilot Program
CP Wire
Thu, 01/3/19 - 09:43 am
suvodirsen
Wave Life Sciences
Duchenne Muscular Dystrophy
muscular dystrophy
Suvodirsen For Duchenne Muscular Dystrophy Selected for FDA Complex Innovative Trial Designs Pilot Program
Thu, 01/3/19 - 09:41 am
suvodirsen
Wave Life Sciences
Duchenne Muscular Dystrophy
muscular dystrophy
Orphan Drug Designation Granted to Investigational Gene Therapy for Rare Form of Muscular Dystrophy
CP Wire
Wed, 01/2/19 - 10:08 am
Limb Girdle Muscular Dystrophy
muscular dystrophy
FDA
Myonexus
NYO-102
gene therapy
Myonexus Therapeutics Starts Trial of First-Ever Gene Therapy for Rare Type of Muscular Dystrophy
CP Wire
Thu, 11/8/18 - 12:11 pm
Myonexus
Sarepta Therapeutics
muscular dystrophy
gene therapy
Myonexus Therapeutics Starts Trial of First-Ever Gene Therapy for Rare Type of Muscular Dystrophy
Thu, 11/8/18 - 09:56 am
Myonexus
Sarepta Therapeutics
muscular dystrophy
The Good, the Bad, and the Ugly of a Competitor's Failure
Motley Fool
Sat, 09/21/13 - 10:11 am
GSK
Prosensa
Duchenne Muscular Dystrophy
muscular dystrophy
eteplirsen
Sarepta Therapeutics
Potential Paradigm Shifting Technology from a Small Biotech
Motley Fool
Sat, 08/3/13 - 10:36 am
Sarepta Therapeutics
eteplirsen
muscular dystrophy
Duchenne Muscular Dystrophy
Buy, Sell, or Hold: Sarepta Therapeutics
Motley Fool
Sat, 12/1/12 - 09:28 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
muscular dystrophy
Will Sarepta Receive Accelerated Approval?
Motley Fool
Sat, 12/1/12 - 09:25 am
Sarepta
eteplirsen
muscular dystrophy
Duchenne Muscular Dystrophy
Sarepta Therapeutics: Tomorrow's Monster Stock
Motley Fool
Sat, 11/24/12 - 11:34 am
Sarepta Therapeutics
eterplirsen
Duchenne Muscular Dystrophy
muscular dystrophy
Step Back From That Overnight Triple, Sir
Motley Fool
Sat, 10/6/12 - 11:47 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
muscular dystrophy
This Drug Could Be a Game-Changer for Sarepta (and a Savior for Thousands)
Motley Fool
Sat, 09/29/12 - 12:26 pm
Sarepta Therapeutics
muscular dystrophy
Biogen Idec Inc. and Isis Pharmaceuticals Inc. to Work Together in a Project
French Tribune, France
Sat, 06/30/12 - 04:32 pm
Biogen Idec
Isis Pharmaceuticals
muscular dystrophy
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy
Yahoo
Fri, 06/29/12 - 12:03 pm
Isis Pharmaceuticals
Biogen Idec
antisense
muscular dystrophy
Drug for rare disease may lift AVI BioPharma shares: Barron's
Yahoo/Reuters
Sun, 04/1/12 - 12:14 pm
AVI BioPharma
eteplirsen
muscular dystrophy
Insmed shares plummet on Iplex study results
Yahoo/AP
Thu, 06/25/09 - 03:22 pm
Insmed
drug trials
IPLEX
muscular dystrophy